We redefine research and development in NLRP3 and inflammatory processes by providing cutting-edge solutions and services, with a special focus on sepsis, multiple sclerosis and other diseases.

Thanks to a patented ex vivo assay that allows us to establish what has happened inside the monocyte and whether or not NLRP3-immune-paralysed, we are